Dana Investment Advisors Inc. lessened its stake in shares of Encore Capital Group, Inc. (NASDAQ:ECPG – Free Report) by 1.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 171,468 shares of the asset manager’s stock after selling 2,301 shares during the quarter. Dana Investment Advisors Inc. owned approximately 0.72% of Encore Capital Group worth $7,155,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also recently added to or reduced their stakes in the company. ProShare Advisors LLC grew its holdings in shares of Encore Capital Group by 7.4% during the first quarter. ProShare Advisors LLC now owns 4,692 shares of the asset manager’s stock worth $214,000 after buying an additional 323 shares in the last quarter. Victory Capital Management Inc. boosted its position in Encore Capital Group by 8.8% during the second quarter. Victory Capital Management Inc. now owns 4,980 shares of the asset manager’s stock worth $208,000 after acquiring an additional 403 shares during the last quarter. Inspire Investing LLC grew its stake in Encore Capital Group by 9.8% in the 2nd quarter. Inspire Investing LLC now owns 8,536 shares of the asset manager’s stock worth $356,000 after acquiring an additional 759 shares during the period. Meeder Asset Management Inc. acquired a new position in Encore Capital Group in the 2nd quarter valued at $33,000. Finally, The Manufacturers Life Insurance Company raised its holdings in Encore Capital Group by 7.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 11,647 shares of the asset manager’s stock valued at $486,000 after acquiring an additional 790 shares during the last quarter.
Insider Activity at Encore Capital Group
In other news, SVP Andrew Eric Asch sold 1,251 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $50.00, for a total value of $62,550.00. Following the transaction, the senior vice president now directly owns 18,075 shares in the company, valued at approximately $903,750. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 2.63% of the stock is owned by insiders.
Encore Capital Group Price Performance
Encore Capital Group (NASDAQ:ECPG – Get Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The asset manager reported $1.34 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.10. The company had revenue of $355.29 million for the quarter, compared to analyst estimates of $346.06 million. Encore Capital Group had a negative net margin of 15.43% and a positive return on equity of 11.12%. Encore Capital Group’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter last year, the business earned $1.08 EPS. As a group, sell-side analysts expect that Encore Capital Group, Inc. will post 5.56 EPS for the current year.
Wall Street Analysts Forecast Growth
Separately, Truist Financial decreased their price objective on Encore Capital Group from $70.00 to $64.00 and set a “buy” rating on the stock in a report on Tuesday, August 20th.
View Our Latest Stock Analysis on ECPG
Encore Capital Group Profile
Encore Capital Group, Inc, a specialty finance company, provides debt recovery solutions and other related services for consumers across financial assets worldwide. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value, as well as manages them by working with individuals as they repay their obligations and works toward financial recovery.
Featured Stories
- Five stocks we like better than Encore Capital Group
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Why Lennar Stock Could Be the Best Play in the Housing Market
- The Risks of Owning Bonds
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What is the Nikkei 225 index?
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Encore Capital Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encore Capital Group and related companies with MarketBeat.com's FREE daily email newsletter.